Skip to main content
Deutsch

Search

  1. Home
  2. Search

Webseiten-Inhalte

Researcher of the MedUni Vienna ...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing... https://www.meduniwien.ac.at/web/en/forschung/researcher-profiles/researcher-profiles/detail/?name=Kilian%20_Kluge&res_id=979&cHash=c39e970a8d18955a9e03d21559118f83
Researcher of the MedUni Vienna ...MuDr. Kilian Kluge Department of Biomedical Imaging and Image-guided Therapy (Clinical Division of Nuclear Medicine)Position: Doctor-in-training ORCID: 0000-0002-4224-7314T +43 1 40400 58739 kilian.kluge@meduniwien.ac.at Research group(s) Christian Doppler Laboratory for Applied MetabolomicsHead: Lukas KennerResearch Area: We investigate ways to better characterize tumors using non-invasive imaging techniques. This is important because tumours are constantly changing through mutations. In this way, an individual therapy should be possible and its success should be continuously monitored.Members: Marko Grahovac David Haberl Lukas Kenner Kilian Kluge Marzieh Nejabat Jing Ning Research interests My research is primarily focused on understanding the connection between (epi)genetic tumor subtypes and their destinct functional imaging phenotypes by contextualizing... https://www.meduniwien.ac.at/web/en/forschung/researcher-profiles/researcher-profiles/detail/?name=Kilian%20_Kluge&res_id=979&cHash=1833f75425c7bf7b11515f58d3867bbf
News ..., sondern sie verlassen auch den Primärtumor und lassen sich in anderen Körperregionen in Form von Metastasen nieder. Ein dafür wesentlich verantwortliches Gen, AF1q, wurde nun von einer internationalen Forschungsgruppe rund um Lukas Kenner von der MedUni Wien und William Tse vom James Graham Brown Cancer... https://www.meduniwien.ac.at/web/index.php?id=131&L=3&tx_news_pi1%5Bnews%5D=2915&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=14478592298920cd61047a6b8595a883
Immune marker analysis: size of tumour tissue area crucial for survival prognosis ... activity in the tumour compared to tissue-sparing punch biopsies. A team led by the visceral surgeon Elisabeth S. Gruber and the molecular pathologist Lukas Kenner from MedUni Vienna demonstrated these findings by immunohistochemical investigation of tumour tissue of rectal cancer patients. With the second... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-maerz/immune-marker-analysis-size-of-tumour-tissue-area-crucial-for-survival-prognosis/medicine-science/?L=3
Immune marker analysis: size of tumour tissue area crucial for survival prognosis ... activity in the tumour compared to tissue-sparing punch biopsies. A team led by the visceral surgeon Elisabeth S. Gruber and the molecular pathologist Lukas Kenner from MedUni Vienna demonstrated these findings by immunohistochemical investigation of tumour tissue of rectal cancer patients. With the second... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-maerz/immune-marker-analysis-size-of-tumour-tissue-area-crucial-for-survival-prognosis/?L=3
Immune marker analysis: size of tumour tissue area crucial for survival prognosis ... activity in the tumour compared to tissue-sparing punch biopsies. A team led by the visceral surgeon Elisabeth S. Gruber and the molecular pathologist Lukas Kenner from MedUni Vienna demonstrated these findings by immunohistochemical investigation of tumour tissue of rectal cancer patients. With the second... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-maerz/immune-marker-analysis-size-of-tumour-tissue-area-crucial-for-survival-prognosis/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=11&cHash=4eec7e5e56ced03058efa23e78c6868c
Immune marker analysis: size of tumour tissue area crucial for survival prognosis ... activity in the tumour compared to tissue-sparing punch biopsies. A team led by the visceral surgeon Elisabeth S. Gruber and the molecular pathologist Lukas Kenner from MedUni Vienna demonstrated these findings by immunohistochemical investigation of tumour tissue of rectal cancer patients. With the second... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-maerz/immune-marker-analysis-size-of-tumour-tissue-area-crucial-for-survival-prognosis/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=2&cHash=f7b8aacc5325df0b91e534c46b12ab37
Neuroblastoma: improved treatment prospects in future ...All News – Medicine & Science (Vienna, 03 December 2019) Neuroblastoma is a rare form of malignant tumour, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-dezember-2020/neuroblastoma-improved-treatment-prospects-in-future/?L=3
Neuroblastoma: improved treatment prospects in future ...All News – Medicine & Science (Vienna, 03 December 2019) Neuroblastoma is a rare form of malignant tumour, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-dezember-2020/neuroblastoma-improved-treatment-prospects-in-future/medicine-science/?L=3
Neuroblastoma: improved treatment prospects in future ...All News – Medicine & Science (Vienna, 03 December 2019) Neuroblastoma is a rare form of malignant tumour, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2019/news-im-dezember-2020/neuroblastoma-improved-treatment-prospects-in-future/?tx_news_pi1%5BoverwriteDemand%5D%5Bcategories%5D=11&cHash=6a9996b8fd5e8e08df425b14a7391736